Anti-ISK5/ SPINK5/ LEKTI functional antibody

Anti-ISK5/ SPINK5/ LEKTI functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SPINK5/SPINK5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1312-Ab-1/ GM-Tg-hg-SE1312-Ab-2Anti-Human SPINK5 monoclonal antibodyHuman
GM-Tg-rg-SE1312-Ab-1/ GM-Tg-rg-SE1312-Ab-2Anti-Rat SPINK5 monoclonal antibodyRat
GM-Tg-mg-SE1312-Ab-1/ GM-Tg-mg-SE1312-Ab-2Anti-Mouse SPINK5 monoclonal antibodyMouse
GM-Tg-cynog-SE1312-Ab-1/ GM-Tg-cynog-SE1312-Ab-2Anti-Cynomolgus/ Rhesus macaque SPINK5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1312-Ab-1/ GM-Tg-felg-SE1312-Ab-2Anti-Feline SPINK5 monoclonal antibodyFeline
GM-Tg-cang-SE1312-Ab-1/ GM-Tg-cang-SE1312-Ab-2Anti-Canine SPINK5 monoclonal antibodyCanine
GM-Tg-bovg-SE1312-Ab-1/ GM-Tg-bovg-SE1312-Ab-2Anti-Bovine SPINK5 monoclonal antibodyBovine
GM-Tg-equg-SE1312-Ab-1/ GM-Tg-equg-SE1312-Ab-2Anti-Equine SPINK5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1312-Ab-1/ GM-Tg-hg-SE1312-Ab-2; GM-Tg-rg-SE1312-Ab-1/ GM-Tg-rg-SE1312-Ab-2;
GM-Tg-mg-SE1312-Ab-1/ GM-Tg-mg-SE1312-Ab-2; GM-Tg-cynog-SE1312-Ab-1/ GM-Tg-cynog-SE1312-Ab-2;
GM-Tg-felg-SE1312-Ab-1/ GM-Tg-felg-SE1312-Ab-2; GM-Tg-cang-SE1312-Ab-1/ GM-Tg-cang-SE1312-Ab-2;
GM-Tg-bovg-SE1312-Ab-1/ GM-Tg-bovg-SE1312-Ab-2; GM-Tg-equg-SE1312-Ab-1/ GM-Tg-equg-SE1312-Ab-2
Products NameAnti-SPINK5 monoclonal antibody
Formatmab
Target NameSPINK5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SPINK5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1312-Ag-1Recombinant multi-species ISK5/ SPINK5/ LEKTI protein


    Target information

    Target IDGM-SE1312
    Target NameSPINK5
    Gene ID11005,72432,361319,709424,478055,101086696,526637,100071873
    Gene Symbol and Synonyms2310065D10Rik,LEKT1,LEKTI,LETK1,LETKI,NETS,NS,SPINK5,VAKT1,VAKTI
    Uniprot AccessionQ9NQ38
    Uniprot Entry NameISK5_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000133710
    Target ClassificationN/A

    The target: SPINK5, gene name: SPINK5, also named as LEKTI, LETKI, NETS, NS, VAKTI. This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.